サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588618

麻酔および呼吸デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年

Anesthesia And Respiratory Devices Market Size, Share & Trends Analysis Report By Product (Respiratory Devices (), Anesthesia Devices), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
麻酔および呼吸デバイスの市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月22日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

麻酔および呼吸デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の麻酔および呼吸デバイス市場規模は、2025年から2030年にかけて5.9%のCAGRを記録し、2030年には759億米ドルに達すると推定されています。

呼吸器疾患の有病率の増加、入院期間の短縮を望む患者の嗜好、政府による資金援助などが主な促進要因です。さらに、高齢化は睡眠時無呼吸症候群発症の最大のリスク要因の1つと考えられており、したがってこの業界にとってインパクトの大きいレンダリング 促進要因になると予想されています。COVID-19の大流行は業界に大きな影響を与えました。セグメントによって影響は異なります。例えば、人工呼吸器分野は、機械式人工呼吸器需要の急激な急増により急激な成長を示しました。

しかし、この需要は2021年以降減少し、業界規模は劇的に縮小しました。ネブライザー分野に関しては、ウイルス感染や免疫抑制の潜在的原因とされる吸入薬の使用により、人々はネブライザーの使用に不安を抱いていました。患者の嗜好が入院期間の短縮にシフトしていることから、麻酔および呼吸デバイス械の採用が増加し、市場の牽引役となることが予想されます。米国病院協会によると、メディケア受給者の約20％が退院後30日以内に再入院しています。回避可能な再入院を特定して減らすことは、ヘルスケアの安全性を向上させ、支出を削減することが期待されます。

そのため、政策立案者は患者の入院日数を減らす努力をしています。患者保護・医療費適正化法（Patient Protection and Affordable Act）において、議会は2013年から病院再入院削減プログラム（Hospital Readmission Reduction Program：HRRP）を開始し、その下でメディケアは再入院率が高い病院に対してペナルティを科すことができるようになった。この法律の施行により、多くの医師や患者が、外来用輸液ポンプや在宅呼吸モニターなどの麻酔・呼吸機器を選択しています。主なプレイヤーは、治療に改善をもたらすために先進的な機器を開発する取り組みを行っています。例えば、2022年5月、Max Ventilator社は、内蔵加湿器と酸素療法からなる非侵襲的（NIV）人工呼吸器を発売しました。この装置は使いやすく軽量で、価格も従来の人工呼吸器より安いです。こうした取り組みにより、今後数年間は業界の成長が促進されると予想されます。

麻酔および呼吸デバイス市場レポートハイライト：

  • 収益面では、慢性閉塞性肺疾患（COPD）、喘息、結核などの有病率の上昇により、呼吸器デバイス分野が2024年に最大の収益シェアを占めました。
  • 麻酔機器分野は、手術件数の増加や市場参入企業によるさまざまな技術進歩により、予測期間中に大きく成長する見込みです。
  • 北米は、同地域の主要プレイヤーの存在により、2024年に最大の収益シェアを占めました。
  • アジア太平洋は、ヘルスケア支出の増加と患者の意識の高まりにより、予測期間中に最も速いCAGRを示すことが期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 麻酔および呼吸デバイス市場の変数、動向、範囲

  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
    • 市場機会
  • 麻酔および呼吸デバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 麻酔および呼吸デバイス市場：製品推定・動向分析

  • 製品タイプ市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 製品タイプ別
    • 麻酔デバイス
    • 呼吸デバイス

第5章 麻酔および呼吸デバイス市場：地域推定・動向分析、製品別

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場のスナップショット
  • 市場規模、予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア/ポジション分析、2023年
  • 企業プロファイル
    • General Electric Company
    • Medtronic
    • Teleflex Incorporated
    • Koninklijke Philips NV
    • Dragerwerk AG &CO. KGAA
    • Getinge AB
    • Smiths Group PLC
    • Fisher &Paykel Healthcare Limited
    • Masimo
    • Braun Melsungen AG
    • ResMed
    • Inogen, Inc.
    • Caire Medical（a subsidiary of NGK Spark Plug）
    • DeVilbiss Healthcare（a subsidiary of Drive Medical）
    • React Health（Respiratory Product Line from Invacare Corporation）
    • O2 Concepts
    • Nidek Medical Products, Inc.
    • Omron Corporation
    • GE Healthcare
    • Allied Healthcare
    • Vectura Group Plc.
    • PARI Respiratory Equipment, Inc.
    • Aerogen
    • DeVilbiss Healthcare LLC
    • Briggs Healthcare
    • Beurer GmBH
図表

List of Tables

  • Table 1 North America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 North America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 3 U.S Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 4 Canada Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 5 Mexico Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 6 Europe Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 7 Europe Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 8 UK Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Germany Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 France Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 11 Italy Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 12 Spain Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 13 Sweden Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 14 Denmark Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 Norway Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 18 China Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 19 Japan Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 India Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 21 Australia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 22 South Korea Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 23 Thailand Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Latin America Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 25 Latin America Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 26 Brazil Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 27 Argentina Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 28 MEA Anesthesia & Respiratory Devices Market, By Region, 2018 - 2030 (USD Million)
  • Table 29 MEA Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 30 South Africa Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Saudi Arabia Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 UAE Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)
  • Table 33 Kuwait Anesthesia & Respiratory Devices Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Aesthesia and respiratory devices market outlook
  • Fig. 9 Aesthesia and respiratory devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthesia and respiratory devices market driver impact
  • Fig. 15 Aesthesia and respiratory devices market restraint impact
  • Fig. 16 Aesthesia and respiratory devices market strategic initiatives analysis
  • Fig. 17 Aesthesia and respiratory devices market: Product movement analysis
  • Fig. 18 Aesthesia and respiratory devices market: Product outlook and key takeaways
  • Fig. 19 Anesthesia devices market, 2018 - 2030 (USD Million)
  • Fig. 20 Anesthesia delivery machines market, 2018 - 2030 (USD Million)
  • Fig. 21 Anesthesia monitors market, 2018 - 2030 (USD Million)
  • Fig. 22 Anesthesia ventilators market, 2018 - 2030 (USD Million)
  • Fig. 23 Anesthesia workstations market, 2018 - 2030 (USD Million)
  • Fig. 24 Anesthesia disposables market, 2018 - 2030 (USD Million)
  • Fig. 25 Anesthesia disposables masks market, 2018 - 2030 (USD Million)
  • Fig. 26 Anesthesia disposable accessories market, 2018 - 2030 (USD Million)
  • Fig. 27 Respiratory devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Positive airway pressure market, 2018 - 2030 (USD Million)
  • Fig. 29 Ventilators market, 2018 - 2030 (USD Million)
  • Fig. 30 Nebulizers market, 2018 - 2030 (USD Million)
  • Fig. 31 Humidifiers market, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory inhalers market, 2018 - 2030 (USD Million)
  • Fig. 33 Oxygen concentrators market, 2018 - 2030 (USD Million)
  • Fig. 34 Reusable resuscitators market, 2018 - 2030 (USD Million)
  • Fig. 35 Pulse oximeters market, 2018 - 2030 (USD Million)Anesthesia Devices
  • Fig. 36 Capnographs market, 2018 - 2030 (USD Million)
  • Fig. 37 Spirometers market, 2018 - 2030 (USD Million)
  • Fig. 38 Peak flow meters market, 2018 - 2030 (USD Million)
  • Fig. 39 Global aesthesia and respiratory devices market: Regional movement analysis
  • Fig. 40 Global aesthesia and respiratory devices market: Regional outlook and key takeaways
  • Fig. 41 Global anesthesia and respiratory devices market share and leading players
  • Fig. 42 North America market share and leading players
  • Fig. 43 Europe market share and leading players
  • Fig. 44 Asia Pacific market share and leading players
  • Fig. 45 Latin America market share and leading players
  • Fig. 46 Middle East & Africa market share and leading players
  • Fig. 47 North America: SWOT
  • Fig. 48 Europe SWOT
  • Fig. 49 Asia Pacific SWOT
  • Fig. 50 Latin America SWOT
  • Fig. 51 MEA SWOT
  • Fig. 52 North America market estimates and forecasts, 2018 - 2030
  • Fig. 53 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 61 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 66 China market estimates and forecasts, 2018 - 2030
  • Fig. 67 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 68 India market estimates and forecasts, 2018 - 2030
  • Fig. 69 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 70 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 73 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 75 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 76 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 77 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 78 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 79 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 80 Market share of key market players- Brain Computer Interface market
  • Fig. 81 Key Company Categorization
  • Fig. 82 Company Market Share/Position Analysis, 2023
  • Fig. 83 Strategic Framework
目次
Product Code: 978-1-68038-557-1

Anesthesia And Respiratory Devices Market Growth & Trends:

The global anesthesia and respiratory devices market size is estimated to reach USD 75.9 billion by 2030, registering a CAGR of 5.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, patient preferences for a reduced hospital stay and supportive government funding are among the key driving factors. Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is, therefore, expected to be a high-impact rendering driver for this industry. The COVID-19 pandemic had a significant impact on the industry. Different segments were impacted differently. For instance, the ventilators segment witnessed exponential growth owing to the sudden surge in the demand for mechanical ventilators.

However, this demand decreased post-2021, wherein the industry size decreased dramatically. Concerning the nebulizers segment, people were apprehensive to use nebulizers owing to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression, which restricted the growth, but did not negatively impact the industry. Shifting the preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from the hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending.

Hence, policymakers are striving to reduce the hospital stays of patients. In the Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP), under which, Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors. Key players are taking initiatives to develop advanced instruments to bring improvement in the treatment. For instance, in May 2022, Max Ventilator launched Non-Invasive (NIV) ventilators consisting of inbuilt humidifiers and oxygen therapy. The device is user-friendly as well as lightweight and is also priced lower than the traditional ventilators. Such initiatives are anticipated to propel industry growth in the coming years.

Anesthesia And Respiratory Devices Market Report Highlights:

  • In terms of revenue, the respiratory devices segment held the largest revenue share in 2024, owing to the rising prevalence of Chronic Obstructive Pulmonary Disease (COPD), asthma, and tuberculosis, among others
  • The anesthesia devices segment is expected to grow significantly over the forecast period, owing to the rising number of surgeries and various technological advancements by market players
  • North America accounted for the largest revenue share in 2024 owing to the presence of major players in the region
  • Asia Pacific is expected to witness the fastest CAGR during the forecast period owing to increasing healthcare expenditure and awareness among patients.

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product outlook
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia and Respiratory Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. Anesthesia and Respiratory Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. COVID-19 Impact Analysis

Chapter 4. Anesthesia and Respiratory Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Brain Computer Interface Market by Product Type Outlook
    • 4.3.1. Anesthesia Devices
      • 4.3.1.1. Anesthesia Devices market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.1.1.1. Anesthesia Machines
          • 4.3.1.1.1.1. Anesthesia Machines market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.2. Anesthesia Workstation
            • 4.3.1.1.1.2.1. Anesthesia Workstation market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.3. Anesthesia Delivery Station
            • 4.3.1.1.1.3.1. Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.1.1.1.3.2. Portable Anesthesia Delivery Station
      • 4.3.1.1.1.3.2.1. Portable Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.1.1.1.3.3. Standalone Anesthesia Delivery Station
      • 4.3.1.1.1.3.3.1. Standalone Anesthesia Delivery Station market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.4. Anesthesia Ventilators
            • 4.3.1.1.1.4.1. Anesthesia Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.1.5. Anesthesia Monitors
            • 4.3.1.1.1.5.1. Anesthesia Monitors market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.1.1.2. Anesthesia Disposables
          • 4.3.1.1.2.1. Anesthesia Disposables market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.2.2. Anesthesia Masks
            • 4.3.1.1.2.2.1. Anesthesia Masks market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.1.1.2.3. Anesthesia Accessories
            • 4.3.1.1.2.3.1. Anesthesia Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Respiratory Devices
      • 4.3.2.1. Respiratory devices market estimates and forecasts, 2018 - 2030 (USD Million)
        • 4.3.2.1.1. Respiratory Equipment's
          • 4.3.2.1.1.1. Respiratory Equipment's market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.2. Humidifiers
            • 4.3.2.1.1.2.1. Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.2. Heat Humidifiers
      • 4.3.2.1.1.2.2.1. Heat Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.3. Heated wire breathing circuits
      • 4.3.2.1.1.2.3.1. Heated wire breathing circuits market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.4. Heat Exchangers
      • 4.3.2.1.1.2.4.1. Heat Exchangers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.2.5. Pass Over Humidifiers
      • 4.3.2.1.1.2.5.1. Pass Over Humidifiers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.3. Nebulizers
            • 4.3.2.1.1.3.1. Nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.2. Pneumatic nebulizers
      • 4.3.2.1.1.3.2.1. Pneumatic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.3. Mesh nebulizers
      • 4.3.2.1.1.3.3.1. Mesh nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.3.4. Ultrasonic nebulizers
      • 4.3.2.1.1.3.4.1. Ultrasonic nebulizers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.4. Oxygen Concentrators
            • 4.3.2.1.1.4.1. Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.4.2. Fixed Oxygen Concentrators
      • 4.3.2.1.1.4.2.1. Fixed Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.4.3. Portable Oxygen Concentrators
      • 4.3.2.1.1.4.3.1. Portable Oxygen Concentrators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.5. Positive airway pressure devices
            • 4.3.2.1.1.5.1. Positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.5.2. Bi-level positive airway pressure devices
      • 4.3.2.1.1.5.2.1. Bi-level positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.5.3. Continuous positive airway pressure devices
      • 4.3.2.1.1.5.3.1. Continuous positive airway pressure devices market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.6. Reusable resuscitators
            • 4.3.2.1.1.6.1. Reusable resuscitators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.7. Ventilators
            • 4.3.2.1.1.7.1. Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.7.2. Adult Ventilators
      • 4.3.2.1.1.7.2.1. Adult Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.7.3. Neonatal Ventilators
      • 4.3.2.1.1.7.3.1. Neonatal Ventilators market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.8. Respiratory inhalers
            • 4.3.2.1.1.8.1. Respiratory inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.8.2. Dry Powdered Inhalers
      • 4.3.2.1.1.8.2.1. Dry Powdered Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.8.3. Meter Dose Inhalers
      • 4.3.2.1.1.8.3.1. Meter Dose Inhalers market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.9. Respiratory disposable
            • 4.3.2.1.1.9.1. Respiratory disposable market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.2. Disposable Oxygen Mask
      • 4.3.2.1.1.9.2.1. Disposable oxygen mask market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.3. Resuscitators
      • 4.3.2.1.1.9.3.1. Resuscitators market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.4. Tracheostomy Tubes
      • 4.3.2.1.1.9.4.1. Tracheostomy Tubes market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.9.5. Oxygen Cannula
      • 4.3.2.1.1.9.5.1. Oxygen Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
          • 4.3.2.1.1.10. Respiratory measurement devices
            • 4.3.2.1.1.10.1. Respiratory measurement devices market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.2. Pulse oximetry systems
      • 4.3.2.1.1.10.2.1. Pulse oximetry systems market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.3. Capnographs
      • 4.3.2.1.1.10.3.1. Capnographs market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.4. Spirometers
      • 4.3.2.1.1.10.4.1. Spirometers market estimates and forecasts, 2018 - 2030 (USD Million)
            • 4.3.2.1.1.10.5. Peak flowmeters
      • 4.3.2.1.1.10.5.1. Peak flowmeters market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Anesthesia and Respiratory Devices Market: Regional Estimates & Trend Analysis, By Product

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Mexico
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. France
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Italy
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Spain
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Norway
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Sweden
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework/ reimbursement structure
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Denmark
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework/ reimbursement structure
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework/ reimbursement structure
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework/ reimbursement structure
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework/ reimbursement structure
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework/ reimbursement structure
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework/ reimbursement structure
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Key company market share/position analysis, 2023
  • 6.4. Company Profiles
    • 6.4.1. General Electric Company
      • 6.4.1.1. Company Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. Medtronic
      • 6.4.2.1. Company Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Teleflex Incorporated
      • 6.4.3.1. Company Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. Koninklijke Philips N.V.
      • 6.4.4.1. Company Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Dragerwerk AG & CO. KGAA
      • 6.4.5.1. Company Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Getinge AB
      • 6.4.6.1. Company Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Smiths Group PLC
      • 6.4.7.1. Company Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. Fisher & Paykel Healthcare Limited
      • 6.4.8.1. Company Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Masimo
      • 6.4.9.1. Company Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Braun Melsungen AG
      • 6.4.10.1. Company Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic initiatives
    • 6.4.11. ResMed
      • 6.4.11.1. Company Overview
      • 6.4.11.2. Financial Performance
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic initiatives
    • 6.4.12. Inogen, Inc.
      • 6.4.12.1. Company Overview
      • 6.4.12.2. Financial Performance
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic initiatives
    • 6.4.13. Caire Medical (a subsidiary of NGK Spark Plug)
      • 6.4.13.1. Company Overview
      • 6.4.13.2. Financial Performance
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic initiatives
    • 6.4.14. DeVilbiss Healthcare (a subsidiary of Drive Medical)
      • 6.4.14.1. Company Overview
      • 6.4.14.2. Financial Performance
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic initiatives
    • 6.4.15. React Health (Respiratory Product Line from Invacare Corporation)
      • 6.4.15.1. Company Overview
      • 6.4.15.2. Financial Performance
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic initiatives
    • 6.4.16. O2 Concepts
      • 6.4.16.1. Company Overview
      • 6.4.16.2. Financial Performance
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic initiatives
    • 6.4.17. Nidek Medical Products, Inc.
      • 6.4.17.1. Company Overview
      • 6.4.17.2. Financial Performance
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic initiatives
    • 6.4.18. Omron Corporation
      • 6.4.18.1. Company Overview
      • 6.4.18.2. Financial Performance
      • 6.4.18.3. Product Benchmarking
      • 6.4.18.4. Strategic initiatives
    • 6.4.19. GE Healthcare
      • 6.4.19.1. Company Overview
      • 6.4.19.2. Financial Performance
      • 6.4.19.3. Product Benchmarking
      • 6.4.19.4. Strategic initiatives
    • 6.4.20. Allied Healthcare
      • 6.4.20.1. Company Overview
      • 6.4.20.2. Financial Performance
      • 6.4.20.3. Product Benchmarking
      • 6.4.20.4. Strategic initiatives
    • 6.4.21. Vectura Group Plc.
      • 6.4.21.1. Company Overview
      • 6.4.21.2. Financial Performance
      • 6.4.21.3. Product Benchmarking
      • 6.4.21.4. Strategic initiatives
    • 6.4.22. PARI Respiratory Equipment, Inc.
      • 6.4.22.1. Company Overview
      • 6.4.22.2. Financial Performance
      • 6.4.22.3. Product Benchmarking
      • 6.4.22.4. Strategic initiatives
    • 6.4.23. Aerogen
      • 6.4.23.1. Company Overview
      • 6.4.23.2. Financial Performance
      • 6.4.23.3. Product Benchmarking
      • 6.4.23.4. Strategic initiatives
    • 6.4.24. DeVilbiss Healthcare LLC
      • 6.4.24.1. Company Overview
      • 6.4.24.2. Financial Performance
      • 6.4.24.3. Product Benchmarking
      • 6.4.24.4. Strategic initiatives
    • 6.4.25. Briggs Healthcare
      • 6.4.25.1. Company Overview
      • 6.4.25.2. Financial Performance
      • 6.4.25.3. Product Benchmarking
      • 6.4.25.4. Strategic initiatives
    • 6.4.26. Beurer GmBH
      • 6.4.26.1. Company Overview
      • 6.4.26.2. Financial Performance
      • 6.4.26.3. Product Benchmarking
      • 6.4.26.4. Strategic initiatives